Northern Trust’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$218M Buy
1,114,219
+35,646
+3% +$6.93M 0.03% 458
2025
Q4
$187M Sell
1,078,573
-74,752
-6% -$13.6M 0.02% 517
2025
Q3
$220M Sell
1,153,325
-25,072
-2% -$4.45M 0.03% 458
2025
Q2
$212M Buy
1,178,397
+6,593
+0.6% +$1.15M 0.03% 466
2025
Q1
$198M Sell
1,171,804
-24,625
-2% -$4.05M 0.03% 475
2024
Q4
$180M Buy
1,196,429
+188,402
+19% +$29.3M 0.03% 501
2024
Q3
$156M Sell
1,008,027
-34,550
-3% -$5.16M 0.03% 499
2024
Q2
$143M Sell
1,042,577
-1,589
-0.2% -$218K 0.02% 510
2024
Q1
$139M Sell
1,044,166
-65,228
-6% -$8.46M 0.02% 518
2023
Q4
$153M Sell
1,109,394
-210,491
-16% -$27.7M 0.03% 491
2023
Q3
$161M Sell
1,319,885
-6,695
-0.5% -$892K 0.03% 473
2023
Q2
$186M Sell
1,326,580
-115,125
-8% -$15.9M 0.04% 425
2023
Q1
$204M Sell
1,441,705
-88,622
-6% -$12.7M 0.04% 406
2022
Q4
$239M Buy
1,530,327
+102,020
+7% +$14.7M 0.05% 358
2022
Q3
$175M Sell
1,428,307
-42,816
-3% -$5.64M 0.04% 402
2022
Q2
$196M Sell
1,471,123
-43,454
-3% -$5.92M 0.04% 376
2022
Q1
$207M Buy
1,514,577
+8,406
+0.6% +$1.17M 0.04% 414
2021
Q4
$261M Buy
1,506,171
+38,994
+3% +$5.93M 0.04% 373
2021
Q3
$213M Buy
1,467,177
+21,594
+1% +$3.16M 0.04% 423
2021
Q2
$191M Sell
1,445,583
-14,217
-1% -$1.86M 0.03% 456
2021
Q1
$187M Sell
1,459,800
-21,800
-1% -$2.69M 0.03% 451
2020
Q4
$177M Sell
1,481,600
-45,269
-3% -$5.52M 0.03% 451
2020
Q3
$175M Buy
1,526,869
+4,206
+0.3% +$497K 0.04% 390
2020
Q2
$174M Sell
1,522,663
-142,249
-9% -$15.1M 0.04% 380
2020
Q1
$134M Sell
1,664,912
-9,221
-0.6% -$955K 0.04% 391
2019
Q4
$179M Sell
1,674,133
-49,692
-3% -$5.18M 0.04% 398
2019
Q3
$185M Sell
1,723,825
-235,411
-12% -$24.2M 0.04% 381
2019
Q2
$199M Sell
1,959,236
-43,446
-2% -$4.17M 0.05% 368
2019
Q1
$180M Buy
2,002,682
+28,266
+1% +$2.45M 0.04% 382
2018
Q4
$164M Buy
1,974,416
+62,591
+3% +$5.87M 0.05% 369
2018
Q3
$206M Sell
1,911,825
-136,774
-7% -$15M 0.05% 343
2018
Q2
$225M Buy
2,048,599
+11,848
+0.6% +$1.23M 0.06% 311
2018
Q1
$204M Sell
2,036,751
-69,837
-3% -$7.15M 0.05% 331
2017
Q4
$207M Sell
2,106,588
-7,676
-0.4% -$728K 0.05% 335
2017
Q3
$198M Buy
2,114,264
+24,344
+1% +$2.58M 0.05% 336
2017
Q2
$232M Sell
2,089,920
-36,134
-2% -$3.82M 0.07% 293
2017
Q1
$209M Buy
2,126,054
+167,440
+9% +$16M 0.06% 310
2016
Q4
$180M Sell
1,958,614
-231,009
-11% -$19.9M 0.06% 331
2016
Q3
$185M Buy
2,189,623
+105,710
+5% +$8.88M 0.06% 326
2016
Q2
$170M Sell
2,083,913
-40,363
-2% -$3.07M 0.06% 334
2016
Q1
$149M Buy
2,124,276
+58,069
+3% +$3.89M 0.05% 364
2015
Q4
$147M Sell
2,066,207
-71,120
-3% -$4.78M 0.05% 358
2015
Q3
$131M Sell
2,137,327
-22,646
-1% -$1.58M 0.04% 398
2015
Q2
$157M Buy
2,159,973
+126,180
+6% +$9.32M 0.05% 374
2015
Q1
$156M Buy
2,033,793
+177,942
+10% +$12.7M 0.05% 369
2014
Q4
$124M Sell
1,855,851
-1,803
-0.1% -$114K 0.04% 428
2014
Q3
$113M Buy
1,857,654
+21,657
+1% +$1.33M 0.04% 446
2014
Q2
$108M Sell
1,835,997
-48,443
-3% -$2.84M 0.03% 467
2014
Q1
$109M Sell
1,884,440
-225,170
-11% -$12.1M 0.03% 462
2013
Q4
$113M Buy
2,109,610
+139,783
+7% +$8.29M 0.04% 430
2013
Q3
$122M Sell
1,969,827
-113,452
-5% -$6.79M 0.04% 388
2013
Q2
$126M Buy
+2,083,279
New +$124M 0.05% 376

Other funds holding DGX

Northern Trust's DGX Position: Q1 2026 in Review

Northern Trust increased its Quest Diagnostics (DGX) stake by 3.3% in Q1 2026, buying an estimated $6.93M and bringing the position to 1,114,219 shares worth $218M. The position accounts for 0.03% of the portfolio, ranked #458.

Northern Trust first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $261M in Q4 2021. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Northern Trust held 1,114,219 shares of Quest Diagnostics worth $218M as of Q1 2026.
  • Northern Trust bought 35,646 Quest Diagnostics shares in Q1 2026, an estimated $6.93M.
  • Quest Diagnostics made up 0.03% of Northern Trust's portfolio in Q1 2026, its #458 holding.
  • Northern Trust first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • Northern Trust's Quest Diagnostics position peaked at $261M in Q4 2021.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.